XP12B

Thuốc Gốc

Small Molecule

XP12B is being developed by Xanodyne Pharmaceuticals for the treatment of menorrhagia (heavy menstrual bleeding). It was granted Fast Track status for this indication by the FDA in November 2004.

Chỉ Định : Investigated for use/treatment in menstrual disorders.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB04928

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading